Former French Open finalist Errani gets 2-month doping ban


1 photo
Save Story
Leer en español

Estimated read time: 1-2 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

LONDON (AP) — Former French Open finalist Sara Errani must serve a two-month doping ban after testing positive for the banned substance letrozole in a test taken in February, the International Tennis Federation said on Monday.

Errani blamed contamination from her mother's breast cancer medication.

"I never took, in my life and during my career, any prohibited substance," Errani said in a statement. "I am extremely disappointed but at the same time at peace with my conscience and aware I haven't done anything wrong."

An adjudication panel ruled that Errani's fault was "at the lower end of the scale," but that she should still be banned for two months from Aug. 3.

The Italian has also been retroactively disqualified from tournaments from Feb. 16 through June 7. Her only notable performance in that period was a semifinal in Rabat, Morocco, in May, plus a second-round loss at Roland Garros.

Errani's ban will end on Oct. 2, precluding her from playing in the U.S. Open.

Errani reached the 2012 French Open final, losing to Maria Sharapova, and has completed a career grand slam in women's doubles with Roberta Vinci.

The 98th-ranked Errani has won nine singles titles and 25 doubles titles in her WTA career. She reached a career-high singles ranking of No. 5 in 2013.

She also helped Italy to three Fed Cup titles.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Photos

Most recent National Sports stories

Related topics

TennisNational Sports
The Associated Press

    ARE YOU GAME?

    From first downs to buzzer beaters, get KSL.com’s top sports stories delivered to your inbox weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast